Obesity Interventions – Market Insights – Latin America

The Latin American obesity intervention market will grow through 2026, driven by an increasing obese population and growth of bariatric surgery utilization as a result of positive clinical results and broader acceptance of these procedures in the region. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for obesity intervention in Latin America across a 10-year period.

In several Latin American countries, sales of intragastric balloons will be bolstered by improved physician marketing and awareness.

Which countries will experience the greatest increase in balloon sales?

Which companies successfully market to physicians and what are their market shares?

Insurance coverage varies across the countries and greatly impacts the types of procedures Latin American patients choose to undergo.

How does the availability of insurance differ across the countries?

How does varying insurance coverage impact patients’ choices of treatment?

Several emerging devices are expected to enter the Latin American market within the forecast period.

Which products will enter the Latin American market and when?

How does the approval process in Latin America impact which emerging products will enter the region?

Table of contents